individualized therapy

You have access
Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal Breast Cancer Patient
MOHAMED E.M. SAEED, ASSIA I. DRIF and THOMAS EFFERTH

Anticancer Research July 2022, 42 (7) 3483-3494; DOI: https://doi.org/10.21873/anticanres.15835
You have access
Independence of Cytotoxic Drug Sensitivity Profiles and Receptor Subtype of Invasive Ductal Breast Carcinoma Demonstrated by the Histoculture Drug Response Assay (HDRA)
KWANG YONG KIM, BONG WHA CHUNG, IK YANG, MOON BO KIM and ROBERT M. HOFFMAN

Anticancer Research December 2014, 34 (12) 7197-7201;
You have access
Progression-free Survival Is Accurately Predicted in Patients Treated with Chemotherapy for Epithelial Ovarian Cancer by the Histoculture Drug Response Assay in a Prospective Correlative Clinical Trial at a Single Institution
PHILL-SEUNG JUNG, DAE-YEON KIM, MOON-BO KIM, SHIN-WHA LEE, JONG-HYEOK KIM, YONG-MAN KIM, YOUNG-TAK KIM, ROBERT M. HOFFMAN and JOO-HYUN NAM

Anticancer Research March 2013, 33 (3) 1029-1034;

Main menu